Robert Monroe, M.D., Ph.D, is a board-certified pathologist and geneticist, serving as VP and Chief Scientific Officer of Oncology at Danaher Diagnostics and CMO at Leica Biosystems, with a background in molecular oncology and co-founding OncoMDx.
Join us at a roundtable discussion, with pathologists Dr. Monroe and Dr. Laser who will provide an overview of RNAscope technology and how it shapes the molecular in situ hybridization (ISH) testing landscape. Attendees will see how RNAscope RNA ISH and automation capability on the BOND platform take ISH to the next level.
